Clinical trial
EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis
NCT03650712
Study timeline
Study start (actual)2019-07-01Date precision: day
Registry last updated2026-10-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cystic Fibrosis-related Diabetesunresolved
Interventions
Oral glucose tolerance testDIAGNOSTIC_TEST
Continuous glucose monitoringDIAGNOSTIC_TEST
Dexa scanDIAGNOSTIC_TEST
Sponsors & collaborators
Katie Larson Odelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03650712 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.